Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1
- PMID: 12796773
- DOI: 10.1038/nm884
Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1
Abstract
Therapeutic angiogenesis is likely to require the administration of factors that complement each other. Activation of the receptor tyrosine kinase (RTK) Flk1 by vascular endothelial growth factor (VEGF) is crucial, but molecular interactions of other factors with VEGF and Flk1 have been studied to a limited extent. Here we report that placental growth factor (PGF, also known as PlGF) regulates inter- and intramolecular cross talk between the VEGF RTKs Flt1 and Flk1. Activation of Flt1 by PGF resulted in intermolecular transphosphorylation of Flk1, thereby amplifying VEGF-driven angiogenesis through Flk1. Even though VEGF and PGF both bind Flt1, PGF uniquely stimulated the phosphorylation of specific Flt1 tyrosine residues and the expression of distinct downstream target genes. Furthermore, the VEGF/PGF heterodimer activated intramolecular VEGF receptor cross talk through formation of Flk1/Flt1 heterodimers. The inter- and intramolecular VEGF receptor cross talk is likely to have therapeutic implications, as treatment with VEGF/PGF heterodimer or a combination of VEGF plus PGF increased ischemic myocardial angiogenesis in a mouse model that was refractory to VEGF alone.
Similar articles
-
Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.Nat Med. 2002 Aug;8(8):831-40. doi: 10.1038/nm731. Epub 2002 Jul 1. Nat Med. 2002. PMID: 12091877
-
Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR.J Biol Chem. 1996 Feb 9;271(6):3154-62. doi: 10.1074/jbc.271.6.3154. J Biol Chem. 1996. PMID: 8621715
-
VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism.Circ Res. 2003 Mar 7;92(4):378-85. doi: 10.1161/01.RES.0000057997.77714.72. Epub 2003 Jan 23. Circ Res. 2003. PMID: 12600898
-
The biology of VEGF and its receptors.Nat Med. 2003 Jun;9(6):669-76. doi: 10.1038/nm0603-669. Nat Med. 2003. PMID: 12778165 Review.
-
Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.Princess Takamatsu Symp. 1994;24:162-70. Princess Takamatsu Symp. 1994. PMID: 8983073 Review.
Cited by
-
Placental growth factor as a protective paracrine effector in the heart.Trends Cardiovasc Med. 2011 Nov;21(8):220-4. doi: 10.1016/j.tcm.2012.05.014. Trends Cardiovasc Med. 2011. PMID: 22902069 Free PMC article. Review.
-
Impaired proliferation of pancreatic beta cells, by reduced placental growth factor in pre-eclampsia, as a cause for gestational diabetes mellitus.Cell Prolif. 2015 Apr;48(2):166-74. doi: 10.1111/cpr.12164. Epub 2015 Jan 16. Cell Prolif. 2015. PMID: 25594238 Free PMC article.
-
Adhesion and degranulation promoting adapter protein (ADAP) is a central hub for phosphotyrosine-mediated interactions in T cells.PLoS One. 2010 Jul 22;5(7):e11708. doi: 10.1371/journal.pone.0011708. PLoS One. 2010. PMID: 20661443 Free PMC article.
-
Histidine-rich glycoprotein (HRGP): Pleiotropic and paradoxical effects on macrophage, tumor microenvironment, angiogenesis, and other physiological and pathological processes.Genes Dis. 2020 Aug 8;9(2):381-392. doi: 10.1016/j.gendis.2020.07.015. eCollection 2022 Mar. Genes Dis. 2020. PMID: 35224154 Free PMC article. Review.
-
Apoptotic mechanisms in the pathogenesis of COPD.Int J Chron Obstruct Pulmon Dis. 2006;1(2):161-71. doi: 10.2147/copd.2006.1.2.161. Int J Chron Obstruct Pulmon Dis. 2006. PMID: 18046893 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases